GFACX
Price
$70.96
Change
+$0.29 (+0.41%)
Updated
Jul 16 closing price
Net Assets
323.95B
PSLGX
Price
$141.80
Change
-$0.03 (-0.02%)
Updated
Jul 16 closing price
Net Assets
6.36B
Interact to see
Advertisement

GFACX vs PSLGX

Header iconGFACX vs PSLGX Comparison
Open Charts GFACX vs PSLGXBanner chart's image
American Funds Growth Fund of Amer C
Price$70.96
Change+$0.29 (+0.41%)
VolumeN/A
Net Assets323.95B
Putnam Sustainable Leaders R6
Price$141.80
Change-$0.03 (-0.02%)
VolumeN/A
Net Assets6.36B
GFACX vs PSLGX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GFACX vs. PSLGX commentary
Jul 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a StrongBuy and PSLGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 324B vs. PSLGX (6.36B). PSLGX pays higher dividends than GFACX: PSLGX (0.69) vs GFACX (0.00). GFACX was incepted earlier than PSLGX: GFACX (24 years) vs PSLGX (7 years). GFACX (1.36) is less costly to investors than PSLGX (0.53). GFACX is a more actively managed with annual turnover of: 25.00 vs. PSLGX (22.00). PSLGX has a lower initial minimum investment than GFACX: PSLGX (0) vs GFACX (250). GFACX annual gain was more profitable for investors over the last year : 7.11 vs. PSLGX (-5.39). GFACX return over 5 years is better than : 35.91 vs. PSLGX (29.24).
GFACXPSLGXGFACX / PSLGX
Total Expense Ratio1.360.53257%
Annual Report Gross Expense Ratio1.360.53257%
Fund Existence24 years7 years-
Gain YTD11.2921.729653%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets324B6.36B5,091%
Annual Yield % from dividends0.000.69-
Returns for 1 year7.11-5.39-132%
Returns for 3 years52.0136.53142%
Returns for 5 years35.9129.24123%
Returns for 10 years63.31N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IKT1.860.06
+3.33%
Inhibikase Therapeutics
MKC71.380.63
+0.89%
McCormick & Company
VTS22.940.06
+0.26%
Vitesse Energy
ADN1.95N/A
N/A
Advent Technologies Holdings Inc.
BTE1.84-0.04
-2.13%
Baytex Energy Corp